×
Close

Download Brochure

Services

Pharmacovigilance Services

We at JSTL offers comprehensive Pharmacovigilance and safety monitoring services from early development support through post-approval initiatives. We have experienced and skilled medical professionals with first-hand knowledge of regulatory requirements.

Aggregate Safety Reporting for Lifecycle Safety Management

At JSTL, we provide comprehensive Aggregate Safety Reporting and Risk Management services that support the continuous evaluation and maintenance of a product's benefit-risk profile throughout its lifecycle. Our solutions are designed to help pharmaceutical, biotechnology, and healthcare organizations meet global regulatory requirements while ensuring the highest standards of patient safety.

Our team of experienced pharmacovigilance and regulatory professionals possesses extensive expertise in the scientific, medical, and regulatory aspects of drug safety. We partner with clients to develop high-quality, evidence-based safety documents that facilitate informed regulatory decision-making and support the safe and effective use of medicinal products worldwide.

Our Expertise Includes

  • Periodic Safety Update Reports (PSURs)
  • Periodic Benefit-Risk Evaluation Reports (PBRERs)
  • Periodic Adverse Drug Experience Report (PADERs)
  • Risk Management Plans (RMPs)
  • Signal Management
  • Health Hazard Evaluation (HHE)
  • Development Safety Update Reports (DSURs)
  • Addendum Clinical Overview (ACO) Reports

Our methodology combines scientific rigor, regulatory intelligence, and a risk-based approach to ensure that safety documentation accurately reflects the evolving safety profile of a product. We focus on delivering concise, compliant, and scientifically sound reports where the depth and scope of information are proportionate to identified risks and regulatory expectations.

By partnering with JSTL, organizations gain a reliable pharmacovigilance partner dedicated to delivering insightful safety assessments, regulatory-compliant reporting, and strategic risk management solutions. Our expertise enables clients to confidently navigate complex regulatory landscapes while supporting the continued availability of safe and effective medicines for patients worldwide.

With over a decade of pharmacovigilance expertise, the JSTL team has successfully drafted and reviewed thousands of aggregate reports for global clients, delivering high-quality, medically sound, and regulatory-compliant submissions across multiple markets.